Transverse Medical raised $10M in Series B2 funding to expand operational infrastructure and grow its teams.
Transverse Medical raised $10M in Series B2 funding to expand operational infrastructure and grow its teams.
04/29/25, 7:20 AM
Location
denverMoney raised
$10 million
Industry
healthcare
Round Type
series b
Investors
Series B1 Investors, Company’s Legacy Lead Investor
Transverse Medical, a Denver-based medical device company, raised $10M in Series B2 funding. The funding will support the expansion of operational infrastructure and growth of engineering, regulatory, and operating teams. Backers included the Company’s Legacy Lead investor and Series B1 investors. Transverse focuses on cerebral embolic protection during TAVR procedures.
Company Info
Location
denver, colorado, united states
Additional Info
Transverse Medical Inc. (TMI) is developing the POINT-GUARD™ Cerebral Embolic Protection (CEP) medical device to address the unmet need for Full Brain Protection and the clinical problem of periprocedural Stroke in Structural Heart Procedures, such as Transcatheter Aortic Valve Replacement (TAVR).